NCT02901587View on ClinicalTrials.gov

Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder

PHASE1CompletedINTERVENTIONAL

Enrollment

119

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

April 18, 2018

Study Completion Date

April 18, 2018

Conditions

SchizophreniaSchizoaffective Disorder

Interventions

DRUG

Lu AF35700 (10 mg/day)

tablets for oral administration once daily

DRUG

Lu AF35700 (30 mg/day)

tablets for oral administration once daily

DRUG

Quetiapine (Seroquel XR® 800 mg/day)

tablets for oral administration once daily

Trial Locations (1)

Unknown

US1104, Long Beach

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY

NCT02901587 - Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder | Biotech Hunter | Biotech Hunter